Sustainability is deep rooted in all our decision making
We always strive to do more in order to positively impact our patients consumers, employees, communities as well as our shareholders. We firmly believed that doing business with a conscience is integral in order to sustain our business success.
LATEST
News Updates
10 OCTOBER 2024
Pharmaniaga Berhad (Pharmaniaga) is pleased to announce the appointment of Messrs Ernst & Young (EY) as its new external auditor, effective 9 October 2024. EY replaces Messrs PricewaterhouseCoopers (PwC), which has resigned following a formal written notice served to the Group on 20 September 2024.
1 OCTOBER 2024
Pharmaniaga Berhad (Pharmaniaga) is pleased to announce the appointment of Dato’ Seri Abdul Razak Jaafar as its new Independent Non-Executive Chairman, effective today. He succeeds Izaddeen Daud, who has held the position since February 2023, and as part of this strategic leadership transition, Izaddeen has been redesignated as Non-Independent Non-Executive Director.
19 SEPTEMBER 2024
Malaysia is set to achieve a significant milestone in healthcare with the production of locally manufactured human insulin, biosimilar and vaccines, following the launch of the country’s first locally owned biopharmaceutical plant by Pharmaniaga Berhad, officiated by Dato’ Seri Mohamed Khaled Nordin, Minister of Defence, today.
21 AUGUST 2024
Pharmaniaga Berhad’s (Pharmaniaga) strategic plan and initiatives placed the Group on the right track of recovery as it delivered robust financial results for the first half ended 30 June 2024 (1H FY2024) with Profit After Tax (PAT) rising to RM30.0 million, up from RM5.1 million in the same period last year.